C07K 14/70585
Cd44
Official title: {cd44}
C07K14/70585 (Cd44) appears on 49 US grants and 74 published applications in this corpus.
Search patents in C07K- Granted patents
- 49
- Published applications
- 74
- Assignees
- 45
- Inventors
- 137
- Latest grant
- 17 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 3 | 0 |
| 1999 | 5 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 1 |
| 2003 | 2 | 3 |
| 2004 | 0 | 2 |
| 2005 | 1 | 2 |
| 2006 | 2 | 5 |
| 2007 | 0 | 4 |
| 2008 | 0 | 0 |
| 2009 | 1 | 3 |
| 2010 | 3 | 2 |
| 2011 | 3 | 5 |
| 2012 | 2 | 3 |
| 2013 | 0 | 5 |
| 2014 | 0 | 2 |
| 2015 | 3 | 1 |
| 2016 | 4 | 3 |
| 2017 | 1 | 7 |
| 2018 | 0 | 0 |
| 2019 | 3 | 3 |
| 2020 | 2 | 5 |
| 2021 | 3 | 4 |
| 2022 | 2 | 2 |
| 2023 | 2 | 6 |
| 2024 | 0 | 2 |
| 2025 | 1 | 3 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Ferritin nanocage for multi-displaying trail trimer and cancer-targeting peptide and use thereof as anticancer agent17 Mar 2026US 12,577,292 B2Kyungpook National University Industry-Academic Cooperation Foundation
- Cancer gene therapy drug4 Nov 2025US 12,459,984 B2National University Corporation Kobe University
- Reducing immune inhibition induced by SIGLEC-155 Dec 2023US 11,834,502 B2Innovative Cellular Therapeutics Holdings, Ltd.
- Isolated polypeptides of CD44 and uses thereof24 Jan 2023US 11,560,417 B2Yissum Research Development Company of the Hebrew University of Jerusalem
- Stem cells expressing mesenchymal and neuronal markers, compositions thereof, and methods of preparation thereof19 Apr 2022US 11,306,290 B2Avita International Ltd.
- Coreceptor chimeric antigen receptor24 Sep 2026US 2026/0284111 A1
- Gene therapy for treating mitochondrial stress4 Dec 2025US 2025/0367329 A1Yissum Research Development Company of the Hebrew University of Jerusalem
- Cd44 glycoepitopes and chimeric vaccine glycoconjugates for cancer therapy and synthesis methods thereof30 Oct 2025US 2025/0333475 A1I3S - Instituto De InvestigaçãO E InovaçãO Em SAúDe, AssociaçãO
- Therapeutic antibody and uses thereof29 May 2025US 2025/0170256 A1Multitude Therapeutics Inc.
- Oncolytic viruses and methods of use thereof for the treatment of cancer22 Aug 2024US 2024/0277792 A1
Most cited
By later US patents
- Isolation and use of solid tumor stem cells89US 6,984,522 B2The Regents of the University of Michigan · 2006
- Isolation and use of solid tumor stem cells68US 7,115,360 B2The Regents of the University of Michigan · 2006
- Method for treating cancer using a Notch4 ligand antagonist52US 7,754,206 B2The Regents of the University of Michigan · 2010
- DNA sequence encoding a lymphocyte adhesion receptor for high endothelium35US 5,002,873 AFred Hutchinson Cancer Research Center · 1991
- CD44-like protein and nucleic acids24US 5,942,417 AHuman Genome Sciences, Inc. · 1999